Alder BioPharma Eyes $124M Offering To Fund Development

Alder BioPharmaceuticals Inc. said Monday that it hopes to raise up to $124.1 million by selling more than 4 million shares, the proceeds of which will go toward the development of...

Already a subscriber? Click here to view full article